Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines

Integrative Genomic Profiling of Human Prostate Cancer

Taylor, B. S., Schultz, N. D., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E. G., Reva, B. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,653 · see citing works

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,191 · see citing works

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works

The mutational landscape of lethal castration-resistant prostate cancer

Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517 · see citing works

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,242 · see citing works

Restoration of p53 function leads to tumour regression in vivo

Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · see citing works

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.

Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215 · see citing works

A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy

Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050 · see citing works

Cellular mechanisms of tumour suppression by the retinoblastoma gene

Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974 · see citing works

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

Kao, J., Salari, K., Bocanegra, M., Choi, Y.-L., Girard, L., Gandhi, J., Kwei, K. A., Hernandez-Boussard, T., Wang, P., Gazdar, A. F., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006146 · Cited by 788 · see citing works

Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 696 · see citing works

TP53 Mutation and Survival in Chronic Lymphocytic Leukemia

Zenz, T., Eichhorst, B. F., Busch, R. M., Denzel, T., Häbe, S., Winkler, D. F. H., Bühler, A., Edelmann, J., Bergmann, M., Hopfinger, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.8762 · Cited by 617 · see citing works

Molecular Stratification of Triple-Negative Breast Cancers

Perou, C. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s1-61 · Cited by 582 · see citing works

Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression

Brady, C. A., Jiang, D., Mello, S. S., Johnson, T. M., Jarvis, L. A., Kozak, M. M., Broz, D. K., Basak, S., Park, E. J., McLaughlin, M. E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.035 · Cited by 533 · see citing works

Structural Rearrangement of the Retinoblastoma Gene in Human Breast Carcinoma

Tang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., & Fung, Y.-K. T. (1988) · Science · doi:10.1126/science.3175651 · Cited by 403 · see citing works

Chk2 kinase — a busy messenger

Bártek, J., Falck, J., & Lukas, J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103059 · Cited by 400 · see citing works

Tailoring to RB: tumour suppressor status and therapeutic response

Knudsen, E. S., & Knudsen, K. E. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2401 · Cited by 345 · see citing works

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

Geisler, S. B., Lønning, P. E., Aas, T., Johnsen, H., Fluge, Ø., Haugen, D. F., Lillehaug, J. R., Akslen, L. A., & Børresen‐Dale, A. (2001) · PubMed · Cited by 326 · see citing works

Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM.

Enoch, T., & Norbury, C. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89093-3 · Cited by 261 · see citing works

pRB plays an essential role in cell cycle arrest induced by DNA damage

Harrington, E. A., Bruce, J. L., Harlow, E., & Dyson, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11945 · Cited by 242 · see citing works

The Petinoblastoma Tumor Suppressor Protein

Wang, J. Y. J., Knudson, E. S., & Welch, P. J. (1994) · Advances in cancer research · doi:10.1016/s0065-230x(08)60834-9 · Cited by 220 · see citing works

Molecular Stratification of Triple-Negative Breast Cancers

Perou, C. M. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s5-39 · Cited by 203 · see citing works

Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells

Lüpertz, R., Wätjen, W., Kahl, R., & Chovolou, Y. (2010) · Toxicology · doi:10.1016/j.tox.2010.03.012 · Cited by 197 · see citing works

Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells

Śliwińska, M. A., Mosieniak, G., Wolanin, K., Babik, A., Piwocka, K., Magalska, A., Szczepanowska, J., Fronk, J., & Sikora, E. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.011 · Cited by 179 · see citing works

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.

Geisler, S. B., Børresen‐Dale, A., Johnsen, H., et al. (2003) · PubMed · Cited by 155 · see citing works

Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1

Laine, A., Sihto, H., Come, C., Rosenfeldt, M. T., Zwolinska, A., Niemelä, M., Khanna, A., Chan, E. K., Kähäri, V.-M., Kellokumpu-Lehtinen, P.-L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0292 · Cited by 130 · see citing works

Doxorubicin Exerts Cytotoxic Effects through Cell Cycle Arrest and Fas-Mediated Cell Death

Kim, H., Lee, Y., & Kim, D. (2009) · Pharmacology · doi:10.1159/000245937 · Cited by 127 · see citing works

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines

Wasielewski, M., Elstrodt, F., Klijn, J. G. M., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9186-z · Cited by 110 · see citing works

Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways

Smeets, S. J., van der Plas, M., Schaaij‐Visser, T. B. M., van Veen, E. A. M., van Meerloo, J., Braakhuis, B. J. M., Steenbergen, R. D. M., & Brakenhoff, R. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25474 · Cited by 104 · see citing works

CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer

Chrisanthar, R., Knappskog, S., Løkkevik, E., Anker, G. B., Østenstad, B., Lundgren, S., Berge, E. O., Risberg, T., Mjaaland, I., Mæhle, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003062 · Cited by 94 · see citing works

Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.

Preudhomme, C., Dervite, I., Wattel, E., Vanrumbeke, M., FLACTIF, M., Laı̈, J. L., Hecquet, B., Copin, M., Nelken, B., & Gosselin, B. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.812 · Cited by 81 · see citing works

RB-Pathway Disruption Is Associated with Improved Response to Neoadjuvant Chemotherapy in Breast Cancer

Witkiewicz, A. K., Ertel, A., McFalls, J. M., Valsecchi, M. E., Schwartz, G. F., & Knudsen, E. S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0903 · Cited by 70 · see citing works

Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance

Lønning, P. E. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.01.005 · Cited by 54 · see citing works

Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers

Lønning, P. E., & Knappskog, S. (2013) · Oncogene · doi:10.1038/onc.2013.48 · Cited by 53 · see citing works

Antitumor mechanisms when pRb and p53 are genetically inactivated

Zhu, L., Lu, Z., & Zhao, H.-T. (2014) · Oncogene · doi:10.1038/onc.2014.399 · Cited by 47 · see citing works

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers

Berge, E. O., Knappskog, S., Geisler, S. B., Staalesen, V., Pacal, M., Børresen‐Dale, A., Puntervoll, P., Lillehaug, J. R., & Lønning, P. E. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-173 · Cited by 32 · see citing works

Concomitant inactivation of the p53‐ and pRB‐ functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

Knappskog, S., Berge, E. O., Chrisanthar, R., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.008 · Cited by 24 · see citing works

Alterations of the retinoblastoma gene in metastatic breast cancer

Berge, E. O., Knappskog, S., Lillehaug, J. R., et al. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9375-y · Cited by 18 · see citing works

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

Hemolytic uremic syndrome in families ? an argentinian experience

Voyer, L. E., Wainsztein, R. E., Quadri, B., et al. (1996) · Pediatric Nephrology · doi:10.1007/bf00863451 · Cited by 3 · see citing works

Concomitant Persistent Pain in Classical Trigeminal Neuralgia – Evidence for Different Subtypes

Maarbjerg, S., Gozalov, A., Olesen, J., & Bendtsen, L. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12384 · Cited by 127 · see citing works

[Concomitant disorders among the mentally retarded].

Haugeberg, G., & Kriz, S. (1990) · PubMed

389: Impact of concomitant operative procedures on left ventricular assist device implantation outcomes

Nelson, D. A., Nelson, K. M., Lloyd, I. E., et al. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.11.410

Concomitant relationship and clinical significance of the arteries and veins of the hand

Li, Z. (2000) · Chinese Journal of Practical Hand Surgery